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Background: Literature data indicate that brain-derived neurotrophic factor (BDNF), cyclic-AMP response
element-binding protein (CREB) and phospho-CREB (pCREB) may have a place in depression. BDNF belongs to
the neurotrophin family that plays an important role in proliferation, survival and differentiation of different cell
populations in the mammalian nervous system. The herbal mixture used in the present study consists of Euphoria
longana, Houttuynia cordata and Dioscorea japonica. The purpose of the present study was to determine the
neuroprotective effect of herbal mixture. We also tested the hypothesis that administration of herbs reverses
memory deficits and promotes the protein expression of BDNF in the mouse brain.
Methods: Mice were randomized into four different treatment groups (n = 10/group). Normal and stress groups
received regular lab chow without stress and under stress conditions, respectively, for 3 weeks. The animals in the
stress group were immobilized for 4 hours a day for 2 weeks. Different doses of herbal mixture (206 and 618 mg/kg)
were administered for 3 weeks to those mice under stress conditions. Mice were analyzed by behavioral tests and
immunoblotting examination in the hippocampus and cortex. An additional in vitro investigation was performed to
examine whether herbs induce neurotoxicity in a human neuroblastoma cell line, SH-SY5Y cells.
Results: No significant toxicity of herbs on human neuroblastoma cells was observed. These herbs demonstrated an
inductive effect on the expression of BDNF, pCREB and pAkt. For spatial working memory test, herbal mixture fed mice
exhibited an increased level of spontaneous alternation (p < 0.01) compared to those in stress conditions. Moreover,
herbal mixture produced highly significant (p < 0.01) reduction in the immobility time in the tail suspension test. Mice
in the herbal mixture groups demonstrated lower serum corticosterone concentration than mice in the stress group
(p < 0.05). Effects of the oral administration of herbal mixture on protein levels of BDNF in the hippocampi and cortices
were significant.
Conclusions: Our study showed that herbal mixture administration has antidepressant effects in mice. It is proposed
that adverse events such as stress and depression can modulate the expression of molecular players of cellular
plasticity in the brain.
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Specific data from the Global Burden of Disease 2010
study confirmed that mental and substance use disorders
account for 7.4% of disease burden worldwide which is
greater than HIV/AIDS and tuberculosis (5.3%), diabetes
(2%) or transport injuries (3.3%) [1]. Depression in par-
ticular is projected to become the leading cause of dis-
ability and the second leading contributor to the global
burden of disease in approximately 10 years [2]. As a het-
erogeneous disorder with unclear etiology, depression in-
cludes disturbance of neurogenesis, genetic predisposition,
deficiency of monoamines, hypercortisolemia, reduction
of neurotrophins, inflammation and oxidative stress [3].
It has been proposed that brain-derived neurotrophic
factor (BDNF), as one of neurotrophins, may be a key
player in depression since it is involved in regulation of
neuronal differentiation, survival, function and plasticity
[4]. This neurotrophic hypothesis of depression claims
that decreased levels of BDNF contribute to the hippo-
campal atrophy seen in depressed patients [5]. Depres-
sive symptoms are also associated with decreased serum
level of BDNF [6]. These evidences have already led to
clinical trials of antidepressant medications for treating
major depression, although there are some gaps in the
clinical outcomes depending on the classes of psycho-
tropic drugs and uncertainty about whether drugs that
specifically target depressive symptoms are feasible and
safe. The transcription of BDNF is dependent on cyclic-
AMP response element-binding protein (CREB).
CREB is a transcriptional factor implicated in the con-
trol of adaptive neuronal responses. It has been found
that calcium ions in neurons bind to a calcium response
element within the BDNF gene which triggers phosphor-
ylation of CREB and subsequent activation of BDNF
transcription [7]. Depression is accompanied by down-
regulated and decreased phosphorylated CREB (pCREB).
A growing number of clinical and experimental studies
have demonstrated that structural and functional modifi-
cations of hippocampus from antidepressant treatments
most likely require the transcription and protein expres-
sion of CREB, despite some inconsistencies in its mRNA
and protein levels depending on the brain regions where
such molecule is expressed [7]. CREB is regulated by sev-
eral pathways including protein kinase B (PKB/Akt).
Antidepressant medications are effective at treating
depression, but discontinuation rates are high because
adverse effects are common [8]. For example, selective
serotonin reuptake inhibitors (SSRIs) frequently cause
gastrointestinal problems, insomnia, headache, anxiety
and sexual dysfunction although they are the most com-
monly prescribed antidepressants [9]. Considering the
side effects of synthetic antidepressants, natural plants
can be alternative sources of new antidepressant drugs
due to their more tolerable and less toxic properties.Therefore, the current study was performed as the pro-
gress toward finding reliable alternatives to depression.
Three different ingredients of traditional Korean medi-
cine for depression were selected to observe the effects of
them in cell culture and animal experiment. Euphoria
longana Lam., especially a dried longan seed extract, con-
tain high levels of antioxidant polyphenolic compounds
[10]. Longan seed extracts are found to possess anticancer
properties by inducing apoptosis [11]. Houttuynia cordata
Thunb. is a single species of its genus and the whole plant
of H. cordata is used for the treatment of diabetes [12].
Reported pharmacological activities of plant include anti-
cancer [13], anti-inflammatory [13] and antioxidant [14].
The rhizome of Dioscorea japonica Thunb. has been used
to strengthen stomach function, improve anorexia, elimin-
ate diarrhea, dilute sputum, and moisturize skin in trad-
itional Chinese medicine [15]. An ethanol extract of the
rhizome of D. japonica showed considerable cytotoxic
activity against some human tumor cell lines [16]. These
three natural plants have been used as traditional herbal
medicines in the treatment of neurological disorders in
Korea. However, few studies have evaluated their anti-
depressant effects. The effects of these three herbs on
BDNF, pCREB and pAkt are currently unknown. In this
experiment, one human neuroblastoma cell line was used
to investigate the neuroprotective effect of herbs. We also
tested the hypothesis that administration of herbs reverses
memory deficits and promotes the protein expression of
BDNF in the mouse brain. To test the hypothesis, three
different settings of neuronal cell culture, behaviour study
and their brains have been used in the present study.Methods
Preparation of herbal extracts
All medicinal herbs used were purchased from DY Herb
(Seoul, Korea). Each herb was boiled in 30% ethanol
mixed filter-purified drinking water for 2 h at 100°C in a
reflux condenser. For the cellular experiment, aqueous
extract of each herb was freeze-dried and the dried extract
was reconstructed with distilled water and filtered through
0.2 μm filter (Millipore, MA, USA). In addition, the result-
ing dry powder of each herb was mixed with the same
ratio and added into the feed in the animal studies.Cell culture
Human neuroblastoma SH-SY5Y cells were obtained
from American Type Culture Collection (Rockville, MD,
USA). Cells were maintained in Dulbecco’s modified
Eagle’s minimum essential medium (DMEM, Invitrogen,
Carlsbad, CA, USA) supplemented with 10% fetal bovine
serum (FBS, Invitrogen, Carlsbad, CA, USA), 100 unit/
ml penicillin and 100 μg/ml streptomycin (Gibco-BRL,
Rockville, MD, USA) with further addition of trypsin-
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95% air and 5% CO2 at 37°C.
Cell viability assay
Cell viability was determined by 3-(4,5-dimethylthizaol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT, Abcam,
Cambridge, MA, USA) assay. SH-SY5Y cells were seeded
in 12-well plates (Corning Incorporated, USA) at a density
of 5 × 103 cells/well, stabilized at 37°C for 16 h in DMEM
medium supplemented with FBS and cultured with the
indicated concentrations of herbs for 24 h. The medium
was removed and the cells were incubated with 2 mg/ml
of MTT solution. After incubation for 4 h at 37°C and 5%
CO2, the supernatants were removed and dimethyl sulfox-
ide (DMSO, Sigma, USA) was added. The reactants were
measured in terms of optical density (OD) at 580 nm with
a microplate reader (UV max, Molecular Devices, USA).
The optical densities were converted into percentages
using the following formula: Cell viability (%) =OD sam-
ple/OD negative control × 100. Negative control cells were
treated with complete DMEM alone.
Quantification of BDNF/pCREB/pAkt expression by
Western blot analysis
SH-SY5Y cells were maintained in serum-free medium
with herbs at 30 μg/ml for 24 h. Cells were then washed
twice with ice-cold PBS and lysed in lysis buffer contain-
ing 62.5 mmol/L Tris–HCl, pH 6.8, 2% SDS, 20% glycerol,
10% 2-mercaptoethanol and protease inhibitors. After in-
cubation for 30 min on ice, cell lysates were centrifuged
and protein concentrations were determined using bi-
cinchoninic acid method (Pierce). Samples of cell lysate
containing 50 μg of total protein were separated by 4-12%
SDS-PAGE and transferred onto nitrocellulose membrane
(Amersham Pharmacia Biotech, Buckinghamshire, UK) by
electroblotting. After blocking with 5% skim milk in
Tris-buffered saline (50 mmol/L Tris–HCl, pH 7.6, 150
mmul/L NaCl, 0.1% Tween-20) for more than 30 min, the
membranes were incubated for 16 h at 4°C with primary
antibodies (anti-BDNF, anti-phosphorylated-CREB, anti-
phosphorylated-Akt, β-actin antibody) and further incu-
bated with horseradish peroxidase-conjugated secondary
antibodies for 1 h. The membranes were visualized by an
enhanced chemiluminescence system (ECL kit; Pierce,
Rockford, IL, USA). Densitometric analysis was performed
by Quantity One (Bio-Rad, Hercules, CA) to scan the sig-
nals. Further assay was carried out to detect BDNF protein
expression in the hippocampus and cortex. The treated
hippocampal and cortical tissues removed and homoge-
nized in lysis buffer containing 50 mM Tris-base (pH 7.5),
150 mM NaCl, 2 mM EDTA, 1% glycerol, 10 mM NaF,
10 mM Na-pyrophosphate, 1% NP-40 and protease inhibi-
tors (0.1 mM phenylmethylsulfonylfluoride, 5 μg/ml apro-
tinin, and 5 μg/ml leupeptin). Thirty μg of tissue lysatewere electrophoresed using SDS-polyacrylamide gels and
transferred to nitrocellulose membranes, which were then
incubated with anti-BDNF (Cell signaling technology,
Beverly, MA, USA) for 16 h at 4°C. After washing with
TBS-T (0.05%), the blots were incubated with horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG, and
the bands were visualized using the ECL system (Thermo
Fisher Scienctific, USA). Band images were obtained
by using a Molecular Imager ChemiDoc XRS+ (Bio-Rad,
Hercules, CA, USA) and band intensity was analyzed
using Image Lab™ software version 2.0.1 (Bio-Rad).
Experimental animals
Protocols for animal use were reviewed and approved by
the Institutional Animal Care and Use Committee at
the Dongguk University Ilsan Hospital and were in ac-
cordance with National Institute of Health guidelines.
Healthy male ICR mice (20–26 g, 6 weeks old) were
obtained from OrientBio (Seoul, Korea) and were allowed
1 week for quarantine and acclimatization. Animals were
housed under the conditions of constant temperature
(22 ± 1°C), relative humidity (55 ± 1%) and 12 h light/
12 h dark cycle (light on at 7:00 am). They were housed
in polycarbonate cages and given tap water and com-
mercial rodent chow (Samyang Feed, Daejeon, Korea) ad
libitum. Forty mice were blindly randomized into four dif-
ferent treatment groups (n = 10/group). Normal and stress
groups received regular lab chow without stress and
under stress conditions, respectively, for 3 weeks. The
animals in the stress group were immobilized for 4 h a
day for 2 weeks by being gently inserted into a flexible
triangle shaped vinyl screen that was closed and secured
with nonallergic adhesive tape. Different doses of herbal
mixture (206 and 618 mg/kg which are equivalent to the
recommended adult human dose of 1000 and 3000 mg/
kg, respectively) were administered for 3 weeks to those
mice under stress conditions. The herbal mixture of E.
longana, H. cordata and D. japonica was in a ratio of
1:1:1 by weight. Lab chow with or without herbal mix-
ture was prepared for a mouse to have 1 g/kg/day which
is equivalent to 7 g/60 kg/day for human and was gamma-
irradiated. In order to examine the nutritional status, body
weight was evaluated in mice that were fed with normal
or herb mixture diet. At the end of experiment period, all
animals were immediately decapitated, and their hippo-
campus and cortex of brains were collected and frozen
at −80°C for following analysis. Blood was collected
from the heart by cardiac puncture prior to the excision
of brain, then after centrifugation serum aliquots were
stored at −70°C for further corticosterone determin-
ation. The concentration of serum corticosterone was
measured with the Corticosterone EIA Kit (Enzo Life Sci-
ences, Farmingdale, NY, USA) in accordance with the
manufacturer’s instructions.
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The apparatus (AP model; O’Hara Co., Tokyo, Japan)
for the step-through passive avoidance test consisted
of two compartments, an illuminated compartment
[100 mm · 120 mm · 100 mm; light at the top of com-
partment (27 W, 3000 lx)] and a dark compartment
(100 mm · 170 mm · 100 mm). The compartments were
separated by a guillotine door. During the training trial,
a mouse was placed in the safe, illuminated compartment.
As the compartment was lit, the mouse stepped through
the opened guillotine door into the dark compartment.
The time spent in the illuminated compartment was de-
fined as the latency time. Three seconds after the mouse
entered the dark compartment, a foot shock (0.3 mA,
50 V, 50 Hz ac for 3 seconds) was delivered to the floor
grids in the dark compartment. The mouse could escape
from the shock only by stepping back to the safe illumi-
nated compartment. Mice remaining in the light chamber
for more than 120 seconds during the learning stage were
excluded from the following retention trial. The retention
trials were carried out at 24 h after the training trial to
evaluate the retention of avoidance memory. The latency
time was measured for up to 300 seconds without deliver-
ing a foot shock. It was judged that the mouse retained
the avoidance memory when it stayed in the illuminated
safe compartment for 300 seconds.
Y-maze test
This behavioral test was performed at 48 h after the pas-
sive avoidance test. The maze was made of black painted
wood; each arm was 40 cm long, 12 cm high, 3 cm wide
at the bottom and 10 cm wide at the top. The arms con-
verged at an equilateral triangular central area that was
4 cm at its longest axis. Each mouse was placed at theFigure 1 Effect of herbs on the cell viability measured by MTT assay.
of 10, 30 and 50 μg/ml of each herb for 24 h. Values are presented as meanscentre of the apparatus and allowed to move freely
through the maze for 8 min. The series of arm entries
was recorded visually. Alternation was defined as succes-
sive entry into the three arms on overlapping triplet sets.
Alternation behavior (%) was calculated as the ratio of
actual alternations to possible alternations (defined as the
number of arm entries minus two) multiplied by 100.
Forced swimming test
Mice were placed in a Plexiglas cylinder 25 cm in height
with a 15 cm internal diameter containing water at a
temperature of 25 ± 1°C and a depth of 10 cm so they
could not escape and could not touch the bottom. Water
was changed between each swim session to prevent pos-
sible effects of an alarm substance released by mice dur-
ing the swim session. There were two swim sessions.
The first was 15 min pre-test swim for 3 days in a row
and a second 5 min swim test. The pre-test facilitates the
development of immobility during the test session
and increases the sensitivity for detecting antidepressant
behavioral effects. The 5 min swim test was used for
analysis of behavior such as swimming, climbing and
immobility.
Tail suspension test
Mice both acoustically and visually isolated were sus-
pended individually by their tails 40 cm above the tabletop
with the use of an adhesive tape placed approximately
1 cm from the tip of the tail. After a few minutes of
vigorous activity, the mice hung passively and completely
motionless. The total immobility period in number of sec-
onds was scored throughout the 6 min test. Mice were
considered immobile with the absence of any limb or body
movements, except for those caused by respiration. AThe human neuroblastoma SH-SY5Y cells were incubated at concentrations
± SEM of six determinations.
Figure 2 Measurement of BDNF level in neuroblastoma SH-SY5Y
cells. To evaluate the protein level of BDNF expression, cells were
incubated with 30 μg/ml herb. For the control, nonincubated cells
were analyzed. The BDNF level in cell lysates was measured by
immunoblotting. Data are presented as means ± SEM of three
determinations. *P < 0.05 vs. control.
Figure 3 Time course of expression of pCREB and pAkt in neuroblast
expression, cells were incubated with 30 μg/ml herb. For the control, nonin
lysates was measured by immunoblotting. Data are presented as means ±
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antidepressant-like effect [17].
Data analysis
All statistical analyses were conducted with SPSS (ver. 19,
Somers, NY, USA). Values are expressed as means ± SEM.
All data were analyzed using Student’s t-test. Statistical
significance was accepted at a p value less than 0.05.
Results
Effect of herbs on cell viability
In order to measure the cytotoxicity of herbs on SH-SY5Y
neuroblastoma cells, a cell viability using MTT assay was
utilized. Cells were treated with herbs at concentrations of
10, 30 and 50 μg/ml for 24 h (Figure 1). The percent-
ages of viable cells were as follows: E. longana 10 μg/ml,
88.53 ± 6.3%; 30 μg/ml, 98.25 ± 6.4%; 50 μg/ml, 99.73 ±
10.1%; H. cordata 10 μg/ml, 93.76 ± 1.6%; 30 μg/ml,
95.83 ± 1.2%; 50 μg/ml, 95.61 ± 1.0%; and D. japonica
10 μg/ml, 96.58 ± 0.9%; 30 μg/ml, 93.22 ± 3.4%; 50 μg/ml,
92.38 ± 2.8%. No significant toxicity of herbs on SH-SY5Y
was observed at the indicated concentrations.
Effect of herbs on BDNF/pCREB/pAkt expression
We looked at the inductive effects of herbs on the expres-
sion of BDNF, pCREB and pAkt in cell extracts. For the
control, nonincubated SH-SY5Y cells were analyzed. The
BDNF expression in the SH-SY5Y cell extracts treated
with herbs was significantly higher than that in the controloma SH-SY5Y cells. To evaluate the protein level of pCREB and pAkt
cubated cells were analyzed. The level of pCREB and pAkt in cell
SEM of three determinations. *P < 0.05 vs. control.
Figure 4 Attenuated effect of herb mixture on stress induced impairment of the Y-maze task and passive avoidance task in mice.
Spontaneous alternation in behavior (A) and the number of arm entries (B) were measured. (C) Mice were subjected to the training trial and the
step-through latency time was measured. Data are presented as means ± SEM of three determinations. *P < 0.05 vs. stress, **P < 0.01 vs. normal,
††P < 0.01 vs. normal.
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Figure 5 Effect of herbal mixture on duration of immobility (A), swimming and climbing (B) behaviors in mice when sampled during
the 5 min swim test. (C) Effect of herbal mixture on the amount of immobility in mice during the tail suspension test. Behavior
was observed during the 6 min test period and scored as mobile or immobile. Data are presented as means ± SEM of three determinations.
*P < 0.05 vs. normal, **P < .01 vs. normal, ††P < 0.01 vs. stress.
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results (figure not shown). To determine the expression of
pCREB and pAkt, the cultures were harvested at 30 min,
1 h and 3 h and immunoblotting was performed on the
cell extracts (Figure 3). Compared to the control, the ex-
pression of pCREB treated with 30 μg/ml of E. longana
was 308 ± 8%, 150 ± 11% and 220 ± 10% at 30 min, 1 h
and 3 h, respectively. For H. cordata, it was 102 ± 11%,
98 ± 15% and 120 ± 12% at 30 min, 1 h and 3 h, respect-
ively. In the case of D. japonica, it was 302 ± 11%, 308 ±
15% and 350 ± 14% at 30 min, 1 h and 3 h, respectively.
The pAkt expression in the cell extracts that were incu-
bated with 30 μg/ml of E. longana was 198 ± 11%, 202 ±
15% and 126 ± 16% at 30 min, 1 h and 3 h, respectively.
For H. cordata, it was 180 ± 11%, 175 ± 10% and 190 ± 9%
at 30 min, 1 h and 3 h, respectively. In the case of D.
japonica, it was 100 ± 10%, 160 ± 12% and 109 ± 17%
at 30 min, 1 h and 3 h, respectively. Overall each herb was
able to induce the expression of pCREB and pAkt regard-
less of time course.
Antidepressant effect of herbal mixture
We examined whether herbal mixture attenuated de-
pression in mice under stress conditions. We first per-
formed the Y-maze test for spatial working memory.
Only the stress mice displayed a reduced level of spon-
taneous alternation in the Y-maze test compared to that
of the normal control group (p < 0.01, Figure 4A). How-
ever, mice in the experimental group, which were fed
herbal mixture for 3 weeks, exhibited an increased level
of spontaneous alternation (p < 0.01, Figure 4A). In ad-
dition, the total number of maze arm entries was not dif-
ferent among the groups (Figure 4B). We then examined
the effects of herbal mixture on learning and memory
using a passive avoidance test. Administration of low dose
herbal mixture attenuated the learning memory impairmentFigure 6 Effects of exposure to chronic stress and herbal mixture on co
group. *P < 0.05 vs. normal, †P < 0.05 vs. stress.induced by stress (p < 0.05, Figure 4C). This finding indi-
cates that herbal mixture improved the stress induced
memory impairment under stress conditions. We further
examined the effect of herbal mixture on the forced swim
test. In 5 min swim test, normal mice were immobile
for 229.91 ± 1.0 sec and stress mice were immobile for
237.20 ± 0.4 sec (p < 0.01, Figure 5A). The immobility was
the sum of the durations of floating, twitching and kicking
behaviors. We observed that herbal mixture administra-
tion did not induce any significant change in immobility
when compared to the stress group. But it trended in favor
of herbal mixture. When climbing and swimming be-
haviors were combined, stress mice were less active with
2.80 ± 0.4 sec than those in normal group with 10.09 ± 1.0
(p < 0.01, Figure 5B). Herbal mixture caused improvement
of activity compared with stress group but as a non-
significant trend. The effects on immobility and swimming
observed after the administration of high dose of herbal
mixture were similar to those observed after the adminis-
tration of low dose of herbal mixture. On the other hand,
herbal mixture produced highly significant reduction in
the immobility time in the tail suspension test (p < 0.01,
Figure 5C). Figure 6 illustrates the serum corticosterone
concentration among groups. Mice in the herbal mixture
groups demonstrated lower serum corticosterone concen-
tration than those in the stress group (p < 0.05). As
expected, mice exposed to the chronic stress paradigm
had elevated corticosterone level compared to those in the
normal group (p <0.05). Effects of the oral administration
of herbal mixture on protein levels of BDNF in the hip-
pocampi and cortices are shown in Figure 7. Statistical
analysis indicated a significant effect of administration
with herbal mixture. There were 54.55% (p < 0.01) and
52.15% (p < 0.01) increase in the levels of BDNF in the
hippocampal tissues after administration with 206 and
618 mg/kg herbal mixture as compared with stress group,rticosterone levels. Data are presented as means ± SEM of ten mice per
Figure 7 Effects of the oral administration of herbal mixture on protein levels of BDNF in the hippocampi (A) and cortices (B). Data are
presented as means ± SEM of three determinations. **P < 0.01 vs. stress.
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ture significantly increased the BDNF level (46.03%, p <
0.01 vs. stress) similar to that of 618 mg/kg herbal mixture
(48.49%, p < 0.01 vs. stress).
Discussion
Numerous medicinal herbs have been employed as a
form of mixture or decoction since their effects can be
manifested after total and final reaction by their con-
stituent compounds when administered to humans. Theherbal mixture used in the present study consists of E.
longana, H. cordata and D. japonica which demon-
strated an inductive effect on the expression of BDNF,
pCREB and pAkt. These herbs have been used as a
therapeutic agent for cerebral disease especially in Korea
in conjunction with Sasang Constitutional Medicine
which takes a typological constitution approach to holistic
medicine by balancing an individual’s psychological, social
and physical aspects to achieve wellness and increased
longevity.
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of herbal mixture in both doses (206 and 618 mg/kg) allevi-
ated stress induced learning and memory deficits for mice
by remaining in the well-lit side of a two compartment
apparatus and not entering the dark where it received
the electrical stimulus. Since mouse innately gravitates
to darkness, the animal has to suppress this instinct
through pairing the aversive stimulus (electrical stimulus)
with the desired compartment (dark chamber). Animals
that do not remember the aversive stimulus will cross over
earlier than animals that remember. In addition, it was
clear that the level of exploratory activities was not af-
fected by the spatial working memory of mice. Herbal
mixture treatment also decreased the immobility time in
the tail suspension test. In order to understand the mo-
lecular mechanism of herbal mixture induced antidepres-
sant effects in the brain, the present study investigated
BDNF protein levels in hippocampus and cortex of mice
under stress and compared values with herbal mixture fed
mice under stress. Treatment with herbal mixture showed
a significant increase in BDNF translation level.
Chronic stress may lead to psychotic symptoms inclu-
ding depression and suicide [18]. Studies have shown
that the hippocampus is affected by stress. Depression
invoked by stress has been associated with neuronal
atrophy and decreased volume of hippocampus [19-21].
Several clinical reports have shown depression-induced
deregulation of serum BDNF concentration. Depressed
patients were characterized by low serum BDNF levels
[6,22,23], implying an inverse relationship between serum
BDNF levels and the severity of depression. Support for
this comes from a number of studies demonstrating that
treatment with antidepressants has been shown to increase
BDNF levels in serum [6,23,24] and plasma [25]. It is spec-
ulated that lower BDNF levels may be caused by dys-
regulation of BDNF expression. This was evidenced
with decreased BDNF mRNA and protein levels in post-
mortem hippocampus and frontal cortex of suicide vic-
tims [26]. Recent reports further support the speculation
that antidepressant treatment increased BDNF protein
levels in serum [27] and in both prefrontal cortex and
hippocampus [28]. In the current study, herbal mixture
administration with low and high dose increased the
BDNF protein levels in hippocampus and cortex com-
pared to the stress group. Herbal mixture might have sig-
nificantly increased the BDNF transcript levels as well
although they were not evaluated in our study.
Several types of stressors have been known to disrupt
BDNF expression. For example, single (one day) or repea-
ted (7 days) immobilization for 2 hours per day markedly
reduced BDNF mRNA levels in the dentate gyrus and
hippocampus [29]. This was later confirmed by other in-
vestigators who used the same stress paradigm [30]. Other
types of stressors such as footshock [31], early maternaldeprivation [32], social defeat [33] and chronic unpre-
dictable stress before pregnancy [34] were correlated with
decreased BDNF expression. In our study using im-
mobilization as a stressor, no significant changes in BDNF
protein level were observed in hippocampus and cortex. It
can be proposed that stress induced changes in BDNF pro-
tein level may be involved in other brain regions. The other
hypothesis is that immobilization stress duration was too
long enough to neutralize the downregulation of BDNF
expression. Interestingly, brief immobilization stress can
induce BDNF expression as part of a compensatory re-
sponse to preserve hippocampal homeostasis to cope with
new stress [35].
Our study provides further data that herbal mixture is
able to modulate serum corticosterone level in mice under
stress conditions. This effect could be either of peripheral
origin through a direct action of herbal mixture on adrenal
glands, or of central origin via the hypothalamic-pituitary-
adrenal axis. The inverse relationship between memory
performance and corticosterone level in stress conditions
from our study confirms the past report that chronic stress
in rodents has mostly impairing effects on memory [36].
Moreover, a long term immobilization stress has been
shown to affect spatial memory [37] which is in accordance
with our data of short term immobilization paradigm.
Conclusions
In conclusion, our study showed that herbal mixture
administration has antidepressant effects in mice. Each
herb induced the expression of BDNF, pCREB and pAkt.
The administration of herbal mixture significantly in-
creased BDNF protein expression in mouse hippocampus
and cortex.
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